Compare Ginkgo Bioworks Holdings Inc (DNA) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.44 (market cap $505.73M), while YieldMax TSLA Option Income Strategy ETF trades at $21.83. The key difference: Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| DNA | TSLY | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $16.14 | $48.25 |
52-Week Low | $5.48 | $20.49 |
Enterprise Value | $607.68M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About YieldMax TSLA Option Income Strategy ETF
TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →
